Meta AnalysisID 1458
阿托品在近视儿童中的安全性：一项Meta分析
CRD42022371729
This meta-analysis aims to assess the safety of atropine in children with myopia.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 1458
- Evidence Id
- 10016
- Core Evidence Id
- 10016
- Source Meta Analysis Id
- 1412
- Herb2 Meta Analysis Id
- HBMA001412
- Crd Id
- CRD42022371729
- Title
- The safety of atropine in children with myopia: a meta-analysis
- Review Question
- This meta-analysis aims to assess the safety of atropine in children with myopia.
- Study Type Included
- RCTs, case-control studies and cohort studies
- Condition Being Studied
- Myopia is a worldwide public health issue. It has been predicted that the global prevalence of myopia will show a significant increase, affecting nearly 5 billion people by 2050. Atropine eye drops is an emerging therapy for myopia control. However, most studies have focused on the efficacy of atropine for myopia control with limited studies reported the safety of atropine in children. Therefore, we will investigate the safety of atropine in children with myopia.
- Participant
- Participants were younger than 18 years and definitely diagnosed as myopia
- Animal
- Human Disease Modelled
- Intervention
- Exposure atropine use.
- Comparator Control
- Main Outcome
- Adverse events of atropine Measures of effect The incidence of adverse events of atropine will be retrieved.
- Outcome Measure
- Additional Outcome
- None Measures of effect None
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Humans
- Contact
- Hong Sun [email protected]
- Organisational Affiliation
- Eye & ENT Hospital, Fudan University
- Funding Source
- None Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> None
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Completed not published
- First Submission Date
- 2022-10-31
- Registration Date
- 2022-11-11
- Anticipated Start Date
- 2022-11-01
- Anticipated Completion Date
- 2023-01-31
- Title Cn
- 阿托品在近视儿童中的安全性：一项Meta分析
- Title En
- The safety of atropine in children with myopia: a meta-analysis
- Bilingual Status
- complete